Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 Months

NCT00385320 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

2640

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Rotavirus

Interventions

BIOLOGICAL: HRV vaccine

Sponsor

GlaxoSmithKline